The global pharmaceutical industry will generate more than $1.16 trillion in sales in 2024, according to Statista. The oncology segment alone is expected to generate $214 billion in sales this year. The pharma industry is expected to grow 6.2% annually, reaching $1.47 trillion by 2028.
Not only are pharmaceutical stocks excellent defensive investments in an uncertain economy, some pharma stocks pay sizable dividends that can be a source of steady income and help offset the impact of inflation.
Here are seven pharmaceutical stocks to buy with dividends of at least 2%, according to Bank of America.
This post originally appeared at U.S. News & World Report.